135 related articles for article (PubMed ID: 11563044)
21. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo.
Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR
Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antineoplastic effects of furo[3,4-d]pyrimidine derivatives.
Machoń Z; Cieplik J
Pol J Pharmacol Pharm; 1988; 40(2):201-8. PubMed ID: 3237569
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antitumor activity of new sulfonamide derivatives of thiadiazolo[3,2-a]pyrimidines.
El-Sayed NS; El-Bendary ER; El-Ashry SM; El-Kerdawy MM
Eur J Med Chem; 2011 Sep; 46(9):3714-20. PubMed ID: 21705114
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of 4'-C-ethynyl-beta-D-arabino- and 4'-C-ethynyl-2'-deoxy-beta- D-ribo-pentofuranosyl pyrimidines, and their biological evaluation.
Kohgo S; Horie H; Ohrui H
Biosci Biotechnol Biochem; 1999 Jun; 63(6):1146-9. PubMed ID: 10427708
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.
Ghorab MM; Ragab FA; Heiba HI; Youssef HA; El-Gazzar MG
Bioorg Med Chem Lett; 2010 Nov; 20(21):6316-20. PubMed ID: 20850308
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of 6-(dibromomethyl)-5-nitropyrimidines as potential antitumor agents.
Thompson MD; Cupps TL; Wise DS; Wotring LL; Townsend LB
J Med Chem; 1997 Feb; 40(5):766-70. PubMed ID: 9057863
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and anticancer activity of 5'-phthaloylnucleosides.
Orzeszko A; Vilpo J; Vilpo L; Kamińska B
Pharmazie; 2003 Mar; 58(3):169-72. PubMed ID: 12685810
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
[TBL] [Abstract][Full Text] [Related]
30. Flavopiridol (L86-8275): selective antitumor activity in vitro and activity in vivo for prostate carcinoma cells.
Drees M; Dengler WA; Roth T; Labonte H; Mayo J; Malspeis L; Grever M; Sausville EA; Fiebig HH
Clin Cancer Res; 1997 Feb; 3(2):273-9. PubMed ID: 9815683
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antitumor evaluation of new polysubstituted thiazole and derived thiazolo[4, 5-d]pyrimidine systems.
Fahmy HT; Rostom SA; Bekhit AA
Arch Pharm (Weinheim); 2002 May; 335(5):213-22. PubMed ID: 12210778
[TBL] [Abstract][Full Text] [Related]
32. Anticancer activities of some newly synthesized pyridine, pyrane, and pyrimidine derivatives.
Amr AG; Mohamed AM; Mohamed SF; Abdel-Hafez NA; Hammam Ael-F
Bioorg Med Chem; 2006 Aug; 14(16):5481-8. PubMed ID: 16713269
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and cytotoxicity of the three-membered aromatic pyrimidine derivatives.
Długosz A
Acta Pol Pharm; 1997; 54(5):357-62. PubMed ID: 9584693
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110alpha inhibitors.
Hayakawa M; Kaizawa H; Moritomo H; Koizumi T; Ohishi T; Yamano M; Okada M; Ohta M; Tsukamoto S; Raynaud FI; Workman P; Waterfield MD; Parker P
Bioorg Med Chem Lett; 2007 May; 17(9):2438-42. PubMed ID: 17339109
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of some new pyrazolo[3,4-d]pyrimidine derivatives of expected anticancer and radioprotective activity.
Ghorab MM; Ragab FA; Alqasoumi SI; Alafeefy AM; Aboulmagd SA
Eur J Med Chem; 2010 Jan; 45(1):171-8. PubMed ID: 19853327
[TBL] [Abstract][Full Text] [Related]
36. Efficient synthesis and biological evaluation of some 2,4-diamino-furo[2,3-d]pyrimidine derivatives.
Hu YG; Wang Y; Du SM; Chen XB; Ding MW
Bioorg Med Chem Lett; 2010 Nov; 20(21):6188-90. PubMed ID: 20850310
[TBL] [Abstract][Full Text] [Related]
37. The unsaturated acyclic nucleoside analogues bearing a sterically constrained (Z)-4'-benzamido-2'-butenyl moiety: Synthesis, X-ray crystal structure study, cytostatic and antiviral activity evaluations.
Benci K; Wittine K; Radan M; Cetina M; Sedić M; Kraljević Pavelić S; Pavelić K; Clercq ED; Mintas M
Bioorg Med Chem; 2010 Sep; 18(17):6249-57. PubMed ID: 20696582
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of 2,8-disubstituted imidazo[1,5-a]pyrimidines with potent antitumor activity.
Matsumoto H; Ikeda K; Nagata N; Takayanagi H; Mizuno Y; Tanaka M; Sasaki T
J Med Chem; 1999 May; 42(9):1661-6. PubMed ID: 10229634
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of nucleosides of 5,7-disubstituted pyrido [2,3-d] pyrimidines and their antibacterial activity.
Gupta A; Prakash L
Boll Chim Farm; 1994 Mar; 133(3):163-6. PubMed ID: 8011277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]